The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells

Anne Brüstle, Dirk Brenner, Christiane B. Knobbe, Philipp A. Lang, Carl Virtanen, Brian M. Hershenfield, Colin Reardon, Sonja M. Lacher, Jürgen Ruland, Pamela S. Ohashi, Tak W. Mak

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Effector functions of inflammatory IL-17-producing Th (Th17) cells have been linked to autoimmune diseases such as experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS). However, what determines Th17 cell encephalitogenicity is still unresolved. Here, we show that after EAE induction, mice deficient for the NF-κB regulator MALT1 (Malt1-/- mice) exhibit strong lymphocytic infiltration in the CNS, but do not develop any clinical signs of EAE. Loss of Malt1 interfered with expression of the Th17 effector cytokines IL-17 and GM-CSF both in vitro and in vivo. In line with their impaired GM-CSF secretion, Malt1-/- Th cells failed to recruit myeloid cells to the CNS to sustain neuroinflammation, whereas autoreactive WT Th cells successfully induced EAE in Malt1-/- hosts. In contrast, Malt1 deficiency did not affect Th1 cells. Despite their significantly decreased secretion of Th17 effector cytokines, Malt1 -/- Th17 cells showed normal expression of lineage-specific transcription factors. Malt1-/- Th cells failed to cleave RelB, a suppressor of canonical NF-κB, and exhibited altered cellular localization of this protein. Our results indicate that MALT1 is a central, cell-intrinsic factor that determines the encephalitogenic potential of inflammatory Th17 cells in vivo.

Original languageEnglish (US)
Pages (from-to)4698-4709
Number of pages12
JournalJournal of Clinical Investigation
Volume122
Issue number12
DOIs
StatePublished - Dec 3 2012
Externally publishedYes

Fingerprint

Th17 Cells
Autoimmune Experimental Encephalomyelitis
Interleukin-17
Granulocyte-Macrophage Colony-Stimulating Factor
Cytokines
Intrinsic Factor
Th1 Cells
Myeloid Cells
Autoimmune Diseases
Multiple Sclerosis
Transcription Factors
Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Brüstle, A., Brenner, D., Knobbe, C. B., Lang, P. A., Virtanen, C., Hershenfield, B. M., ... Mak, T. W. (2012). The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells. Journal of Clinical Investigation, 122(12), 4698-4709. https://doi.org/10.1172/JCI63528

The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells. / Brüstle, Anne; Brenner, Dirk; Knobbe, Christiane B.; Lang, Philipp A.; Virtanen, Carl; Hershenfield, Brian M.; Reardon, Colin; Lacher, Sonja M.; Ruland, Jürgen; Ohashi, Pamela S.; Mak, Tak W.

In: Journal of Clinical Investigation, Vol. 122, No. 12, 03.12.2012, p. 4698-4709.

Research output: Contribution to journalArticle

Brüstle, A, Brenner, D, Knobbe, CB, Lang, PA, Virtanen, C, Hershenfield, BM, Reardon, C, Lacher, SM, Ruland, J, Ohashi, PS & Mak, TW 2012, 'The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells', Journal of Clinical Investigation, vol. 122, no. 12, pp. 4698-4709. https://doi.org/10.1172/JCI63528
Brüstle A, Brenner D, Knobbe CB, Lang PA, Virtanen C, Hershenfield BM et al. The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells. Journal of Clinical Investigation. 2012 Dec 3;122(12):4698-4709. https://doi.org/10.1172/JCI63528
Brüstle, Anne ; Brenner, Dirk ; Knobbe, Christiane B. ; Lang, Philipp A. ; Virtanen, Carl ; Hershenfield, Brian M. ; Reardon, Colin ; Lacher, Sonja M. ; Ruland, Jürgen ; Ohashi, Pamela S. ; Mak, Tak W. / The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells. In: Journal of Clinical Investigation. 2012 ; Vol. 122, No. 12. pp. 4698-4709.
@article{4e5a6c93d93e4ea09ebec406fcd707be,
title = "The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells",
abstract = "Effector functions of inflammatory IL-17-producing Th (Th17) cells have been linked to autoimmune diseases such as experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS). However, what determines Th17 cell encephalitogenicity is still unresolved. Here, we show that after EAE induction, mice deficient for the NF-κB regulator MALT1 (Malt1-/- mice) exhibit strong lymphocytic infiltration in the CNS, but do not develop any clinical signs of EAE. Loss of Malt1 interfered with expression of the Th17 effector cytokines IL-17 and GM-CSF both in vitro and in vivo. In line with their impaired GM-CSF secretion, Malt1-/- Th cells failed to recruit myeloid cells to the CNS to sustain neuroinflammation, whereas autoreactive WT Th cells successfully induced EAE in Malt1-/- hosts. In contrast, Malt1 deficiency did not affect Th1 cells. Despite their significantly decreased secretion of Th17 effector cytokines, Malt1 -/- Th17 cells showed normal expression of lineage-specific transcription factors. Malt1-/- Th cells failed to cleave RelB, a suppressor of canonical NF-κB, and exhibited altered cellular localization of this protein. Our results indicate that MALT1 is a central, cell-intrinsic factor that determines the encephalitogenic potential of inflammatory Th17 cells in vivo.",
author = "Anne Br{\"u}stle and Dirk Brenner and Knobbe, {Christiane B.} and Lang, {Philipp A.} and Carl Virtanen and Hershenfield, {Brian M.} and Colin Reardon and Lacher, {Sonja M.} and J{\"u}rgen Ruland and Ohashi, {Pamela S.} and Mak, {Tak W.}",
year = "2012",
month = "12",
day = "3",
doi = "10.1172/JCI63528",
language = "English (US)",
volume = "122",
pages = "4698--4709",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "12",

}

TY - JOUR

T1 - The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells

AU - Brüstle, Anne

AU - Brenner, Dirk

AU - Knobbe, Christiane B.

AU - Lang, Philipp A.

AU - Virtanen, Carl

AU - Hershenfield, Brian M.

AU - Reardon, Colin

AU - Lacher, Sonja M.

AU - Ruland, Jürgen

AU - Ohashi, Pamela S.

AU - Mak, Tak W.

PY - 2012/12/3

Y1 - 2012/12/3

N2 - Effector functions of inflammatory IL-17-producing Th (Th17) cells have been linked to autoimmune diseases such as experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS). However, what determines Th17 cell encephalitogenicity is still unresolved. Here, we show that after EAE induction, mice deficient for the NF-κB regulator MALT1 (Malt1-/- mice) exhibit strong lymphocytic infiltration in the CNS, but do not develop any clinical signs of EAE. Loss of Malt1 interfered with expression of the Th17 effector cytokines IL-17 and GM-CSF both in vitro and in vivo. In line with their impaired GM-CSF secretion, Malt1-/- Th cells failed to recruit myeloid cells to the CNS to sustain neuroinflammation, whereas autoreactive WT Th cells successfully induced EAE in Malt1-/- hosts. In contrast, Malt1 deficiency did not affect Th1 cells. Despite their significantly decreased secretion of Th17 effector cytokines, Malt1 -/- Th17 cells showed normal expression of lineage-specific transcription factors. Malt1-/- Th cells failed to cleave RelB, a suppressor of canonical NF-κB, and exhibited altered cellular localization of this protein. Our results indicate that MALT1 is a central, cell-intrinsic factor that determines the encephalitogenic potential of inflammatory Th17 cells in vivo.

AB - Effector functions of inflammatory IL-17-producing Th (Th17) cells have been linked to autoimmune diseases such as experimental autoimmune encephalomyelitis (EAE), a mouse model of multiple sclerosis (MS). However, what determines Th17 cell encephalitogenicity is still unresolved. Here, we show that after EAE induction, mice deficient for the NF-κB regulator MALT1 (Malt1-/- mice) exhibit strong lymphocytic infiltration in the CNS, but do not develop any clinical signs of EAE. Loss of Malt1 interfered with expression of the Th17 effector cytokines IL-17 and GM-CSF both in vitro and in vivo. In line with their impaired GM-CSF secretion, Malt1-/- Th cells failed to recruit myeloid cells to the CNS to sustain neuroinflammation, whereas autoreactive WT Th cells successfully induced EAE in Malt1-/- hosts. In contrast, Malt1 deficiency did not affect Th1 cells. Despite their significantly decreased secretion of Th17 effector cytokines, Malt1 -/- Th17 cells showed normal expression of lineage-specific transcription factors. Malt1-/- Th cells failed to cleave RelB, a suppressor of canonical NF-κB, and exhibited altered cellular localization of this protein. Our results indicate that MALT1 is a central, cell-intrinsic factor that determines the encephalitogenic potential of inflammatory Th17 cells in vivo.

UR - http://www.scopus.com/inward/record.url?scp=84870521827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870521827&partnerID=8YFLogxK

U2 - 10.1172/JCI63528

DO - 10.1172/JCI63528

M3 - Article

C2 - 23114599

AN - SCOPUS:84870521827

VL - 122

SP - 4698

EP - 4709

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 12

ER -